Literature DB >> 15480793

Diet and the frequency of the alanine:glyoxylate aminotransferase Pro11Leu polymorphism in different human populations.

Elizabeth F Caldwell1, Lianne R Mayor, Mark G Thomas, Christopher J Danpure.   

Abstract

The intermediary metabolic enzyme alanine:glyoxylate aminotransferase (AGT) contains a Pro11Leu polymorphism that decreases its catalytic activity by a factor of three and causes a small proportion to be mistargeted from its normal intracellular location in the peroxisomes to the mitochondria. These changes are predicted to have significant effects on the synthesis and excretion of the metabolic end-product oxalate and the deposition of insoluble calcium oxalate in the kidney and urinary tract. Based on the evolution of AGT targeting in mammals, we have previously hypothesised that this polymorphism would be advantageous for individuals who have a meat-rich diet, but disadvantageous for those who do not. If true, the frequency distribution of Pro11Leu in different extant human populations should have been shaped by their dietary history so that it should be more common in populations with predominantly meat-eating ancestral diets than it is in populations in which the ancestral diets were predominantly vegetarian. In the present study, we have determined frequency of Pro11Leu in 11 different human populations with divergent ancestral dietary lifestyles. We show that the Pro11Leu allelic frequency varies widely from 27.9% in the Saami, a population with a very meat-rich ancestral diet, to 2.3% in Chinese, who are likely to have had a more mixed ancestral diet. FST analysis shows that the differences in Pro11Leu frequency between some populations (particularly Saami vs Chinese) was very high when compared with neutral loci, suggesting that its frequency might have been shaped by dietary selection pressure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15480793     DOI: 10.1007/s00439-004-1191-x

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  30 in total

Review 1.  Variable peroxisomal and mitochondrial targeting of alanine: glyoxylate aminotransferase in mammalian evolution and disease.

Authors:  C J Danpure
Journal:  Bioessays       Date:  1997-04       Impact factor: 4.345

2.  Y chromosome evidence for Anglo-Saxon mass migration.

Authors:  Michael E Weale; Deborah A Weiss; Rolf F Jager; Neil Bradman; Mark G Thomas
Journal:  Mol Biol Evol       Date:  2002-07       Impact factor: 16.240

3.  The nutrient density of present-day and traditional diets and their health aspects: the Sami- and lumberjack families living in rural areas of Northern Sweden.

Authors:  L Håglin
Journal:  Int J Circumpolar Health       Date:  1999-01       Impact factor: 1.228

4.  Biochemical and genetic diagnosis of the primary hyperoxalurias: a review.

Authors:  G Rumsby
Journal:  Mol Urol       Date:  2000

5.  Distribution of gene frequency as a test of the theory of the selective neutrality of polymorphisms.

Authors:  R C Lewontin; J Krakauer
Journal:  Genetics       Date:  1973-05       Impact factor: 4.562

6.  The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract.

Authors:  W G Robertson; P J Heyburn; M Peacock; F A Hanes; R Swaminathan
Journal:  Clin Sci (Lond)       Date:  1979-09       Impact factor: 6.124

7.  Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations.

Authors:  M J Lumb; C J Danpure
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

8.  Differential enzyme targeting as an evolutionary adaptation to herbivory in carnivora.

Authors:  Graeme M Birdsey; Jackie Lewin; Andrew A Cunningham; Michael W Bruford; Christopher J Danpure
Journal:  Mol Biol Evol       Date:  2004-01-22       Impact factor: 16.240

9.  Immunocytochemical localization of human hepatic alanine: glyoxylate aminotransferase in control subjects and patients with primary hyperoxaluria type 1.

Authors:  P J Cooper; C J Danpure; P J Wise; K M Guttridge
Journal:  J Histochem Cytochem       Date:  1988-10       Impact factor: 2.479

10.  Nutrient intake among Saami people today compared with an old, traditional Saami diet.

Authors:  L Håglin
Journal:  Arctic Med Res       Date:  1991
View more
  6 in total

1.  Primary hyperoxaluria type III--a model for studying perturbations in glyoxylate metabolism.

Authors:  Ruth Belostotsky; James Jonathon Pitt; Yaacov Frishberg
Journal:  J Mol Med (Berl)       Date:  2012-06-24       Impact factor: 4.599

2.  Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria.

Authors:  Katharina Hopp; Andrea G Cogal; Eric J Bergstralh; Barbara M Seide; Julie B Olson; Alicia M Meek; John C Lieske; Dawn S Milliner; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

3.  Genomic alterations in biliary atresia suggest region of potential disease susceptibility in 2q37.3.

Authors:  Melissa Leyva-Vega; Jennifer Gerfen; Brian D Thiel; Dorota Jurkiewicz; Elizabeth B Rand; Joanna Pawlowska; Diana Kaminska; Pierre Russo; Xiaowu Gai; Ian D Krantz; Binita M Kamath; Hakon Hakonarson; Barbara A Haber; Nancy B Spinner
Journal:  Am J Med Genet A       Date:  2010-04       Impact factor: 2.802

Review 4.  Lifestyle, genetics, and disease in Sami.

Authors:  Alastair B Ross; Asa Johansson; Max Ingman; Ulf Gyllensten
Journal:  Croat Med J       Date:  2006-08       Impact factor: 1.351

Review 5.  Dietary recommendations and treatment of patients with recurrent idiopathic calcium stone disease.

Authors:  W G Robertson
Journal:  Urolithiasis       Date:  2015-12-08       Impact factor: 3.436

6.  Exploring the relationship between lifestyles, diets and genetic adaptations in humans.

Authors:  Cristina Valente; Luis Alvarez; Sarah J Marks; Ana M Lopez-Parra; Walther Parson; Ockie Oosthuizen; Erica Oosthuizen; António Amorim; Cristian Capelli; Eduardo Arroyo-Pardo; Leonor Gusmão; Maria J Prata
Journal:  BMC Genet       Date:  2015-05-28       Impact factor: 2.797

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.